ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 146 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $435,865 | +80169.8% | 17,900 | +11.2% | 0.00% | 0.0% |
| Q1 2024 | $543 | -31.6% | 16,100 | -36.1% | 0.00% | -33.3% |
| Q4 2023 | $794 | +46.8% | 25,200 | +18.9% | 0.00% | +50.0% |
| Q3 2023 | $541 | -21.0% | 21,200 | -11.3% | 0.00% | -33.3% |
| Q2 2023 | $685 | -98.9% | 23,900 | +455.8% | 0.00% | – |
| Q3 2022 | $63,000 | -6.0% | 4,300 | 0.0% | 0.00% | – |
| Q2 2022 | $67,000 | -41.7% | 4,300 | 0.0% | 0.00% | – |
| Q1 2022 | $115,000 | -27.7% | 4,300 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $159,000 | -22.4% | 4,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $205,000 | +336.2% | 4,300 | +290.9% | 0.00% | – |
| Q4 2020 | $47,000 | -66.7% | 1,100 | -66.7% | 0.00% | -100.0% |
| Q3 2020 | $141,000 | -8.4% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $154,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 204,673 | $10,164,000 | 6.19% |
| CVI Holdings, LLC | 200,032 | $9,349,000 | 3.47% |
| DAFNA Capital Management LLC | 149,017 | $6,965,000 | 2.01% |
| Cormorant Asset Management, LP | 800,000 | $37,392,000 | 1.43% |
| ARK Investment Management | 1,918,835 | $89,686,000 | 0.96% |
| EAM Global Investors LLC | 30,948 | $1,447,000 | 0.65% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,362,000 | 0.61% |
| Monashee Investment Management LLC | 79,497 | $3,716,000 | 0.56% |
| EAM Investors, LLC | 40,695 | $1,902,000 | 0.42% |
| Diametric Capital, LP | 11,478 | $536,000 | 0.41% |